Acquisition of electronic data capture (EDC) vendor makes ClinPhone first company in the biopharmaceutical sector to offer a comprehensive suite of clinical trial management and data capture systems
The deal could be worth up to US$68.768 million (approximately £36.5 million) to the shareholders of DataLabs if the company meets certain performance targets.
All employees within its current headquarters in Irvine, CA and its satellite operations office in Conshohocken, PA will integrate into the ClinPhone organisation.
ClinPhone has already commenced the integration of the acquired EDC technology with its industry renowned solutions, including randomisation and trial supply management (IVR and IWR), clinical trials management software (CTMS) and electronic patient reported outcomes (ePRO) services.
This unique combination of clinical trials software and services provides its pharmaceutical, biotech and CRO clients with a complete end-to-end clinical technology platform.
Sponsors can take advantage of a 'one-stop-shop' technology transfer or a service, custom built to individual project requirements.
Since its inception in 1999, DataLabs has developed a robust spectrum of software designed to streamline and simplify the data collection process, while promoting greater data integrity.
These products include electronic data capture, site management, end-user training and validation and compliance tools.
Additionally, both ClinPhone and DataLabs will seek to harness the combined power of their integration products to facilitate the sharing of information between disparate systems and dramatically reduce the time, cost and risk of integration projects.
Commenting on the acquisition, ClinPhone's CEO Steve Kent highlights, "The assimilation of an established electronic data capture product with our suite of IVR, IWR, CTMS and ePRO solutions gives sponsors a choice that they haven't previously enjoyed.
"We are already working with clients to manage all other aspects of their clinical trial and we can now collect submission data on their behalf too.
"We are first to market with this integrated technology offering and our aim is to create lasting value for all clients throughout the industry".
William Maya, former CEO of DataLabs confirms: "This acquisition represents an incredibly exciting opportunity for the clinical trials industry.
"ClinPhone has long been recognised for its thought leadership in this space and the introduction of our powerful EDC and Site Management software serves to reinforce its market leadership.
"Both our staff and clients are fully committed to ensuring ongoing success for the new organisation".
The new organisation now has more than 700 full time staff across North America, Europe and Australasia including a 24 hour client support desk and operational project management of over 450 employees plus 100 software development engineers.
